ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Dafalgan DOLO 500 mg, Brausetabletten - 16
69265001 UPSA Switzerland AG
Dafalgan DOLO 500 mg, Brausetabletten01.05.2024
  01.05.2024
Paracetamol (N02BE01) 
WHO-DDD30.04.2029
16
01.01.10. 
D  
No 
IPCI
PR  
k.A.PR
  
7680692650016Synthetika
  
Composition
paracetamolum 500 mg, acidum citricum, natrii hydrogenocarbonas, natrii carbonas, sorbitolum 126.1 mg, E 211 50 mg, aromatica (Grapefruit/Orange) cum glucosum 0.83 mg et fructosum 0.96 mg et saccharum 0.28 mg, saccharinum natricum, povidonum K 30, natrii docusas, pro compresso corresp. natrium 197 mg.
Packungsbestandteile
Effervescent tablets
 
Active AgentDose
Paracetamol500 mg
 
Inactive agentsDoseadditional_information
Citric Acid  
Aromatica (Grapefruit/orange) cum Glucosum0.83 mg 
E 21150 mgconserv.
Fructosum0.96 mg 
Sodium Carbonate  
Natrii Docusas  
Sodium Hydrogen Carbonate  
Povidonum K30  
Pro Compresso  
Saccharinum Natricum  
Saccharum0.28 mg 
Sorbitol126.1 mg 
Source
Data was imported : 07.08.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home